Careers  |  Media  |  Contact us

Oncolife HRR 15 Gene (Germline+Somatic)

Test Name

Oncolife HRR 15 Gene (Germline+Somatic)

Home Collection, Lab Visit

Test Code

ONCO0067

Test Components/ Genes/ Parameters

ATM, BARD1, BRCA1, BRCA2, BRIP1, CDK12,CHEK1, CHEK2,FANCL, PALB2,PPP2R2A, RAD51B,RAD51C, RAD51D, RAD54L

Sample Report

Click on Icon

Test Information

TAT DETAILS

21 days

PRE-TEST INSTRUCTIONS

Submit formalin fixed paraffin embedded Tissue Block. Ship at room temperature OR 4 mL (2 mL min.) Whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. Duly filled BRCA 1 & 2 informed consent form for hereditary testing (Form 24) is mandatory.

CLINICAL UTILITY

Offers important value addition to the patient by identifying mutations in 15 genes which are predictive biomarkers for PARP inhibitor therapy.

SPECIMEN STABILITY

Transport at ambient (18-25°C) temperature

METHODOLOGY

NGS

STORAGE TEMPERATURE

NA

SPECIMEN TYPE

Surgical tissue/Tissue Block

Frequently Asked Questions

Oncolife HRR 15 Gene (Germline+Somatic)
Offers important value addition to the patient by identifying mutations in 15 genes which are predictive biomarkers for PARP inhibitor therapy.
The patient should carry the FFPE tissue or block of the effected Breast. This process is carried out by Breast Surgeon in the hospital
The test is recommended when there is a family history of Breast & Prostate Cancer
The test is performed with the Next generation sequencing technique
There is no risk associated with the test as biopsy will be taken by the trained surgeon in the hospital under anasthesia
Result is reported as Pathogenic/No pathogenic or likely pathogenic variants causative of the reported phenotype were identified. Correlation with clinical profile and family history is required